Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge
Autor: | Leonardo Régis Leira Pereira, Osvaldo de Freitas, Angela Achcar, Thais Rodrigues Penaforte, Maurílio de Souza Cazarim |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
Male
lcsh:Medicine Blood Pressure Disease 030204 cardiovascular system & hematology Pharmacists Vascular Medicine Biochemistry 030226 pharmacology & pharmacy 0302 clinical medicine Risk Factors Outcome Assessment Health Care Medicine and Health Sciences lcsh:Science Multidisciplinary Pharmaceutics Drugs Middle Aged After discharge Professions Antihypertensive Drugs Cholesterol Health Education and Awareness Cardiovascular Diseases Hypertension Female Risk assessment Brazil Research Article Adult medicine.medical_specialty Lipoproteins Risk Assessment 03 medical and health sciences Pharmacotherapy Drug Therapy medicine Humans cardiovascular diseases Intensive care medicine Primary Care Antihypertensive Agents Triglycerides Retrospective Studies Pharmacology Impact assessment business.industry Cholesterol HDL lcsh:R Biology and Life Sciences Proteins Reproducibility of Results Retrospective cohort study Cholesterol LDL nervous system diseases Health Care DOENÇAS CARDIOVASCULARES Pharmaceutical care Blood pressure Pharmaceutical Services People and Places Population Groupings lcsh:Q business Follow-Up Studies Program Evaluation |
Zdroj: | PLoS ONE, Vol 11, Iss 6, p e0155204 (2016) Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP PLoS ONE |
ISSN: | 1932-6203 |
Popis: | Introduction Almost 50% of the 17.5 million deaths worldwide from cardiovascular disease have been associated with systemic arterial hypertension (SAH). Into this scenario, Pharmaceutical Care (PC) has been inserted in order to improve the management of SAH and reduce its risks. Objective To evaluate the outcomes and healthcare assistance achieved after discharge of hypertension patients from the PC program. Methods This is a quasi-experimental study with historical controls. Retrospective data collection from 2006 to 2012 was begun in 2013 and included a PC program performed over one year. PC was performed in two basic units of the public health system in Ribeirão Preto-SP, Brazil, where the pharmacist followed up 104 hypertensive patients. The clinical indicators of systolic (SBP) and diastolic blood pressure (DBP), triglycerides, total-cholesterol, high and low density lipoprotein cholesterol were collected, as well as care indicators related to the number of consultations (basic, specialized and emergency care) and antihypertensive drugs used. The coronary risk of patients by the Framingham risk score was also calculated. For the analysis, the data were divided into three periods, 2006–2008 as pre-PC, 2009 as PC and 2010–2012 as post-PC. Results In the pre-PC period, 54.4%, 79.0% and 27.3% of patients presented satisfactory levels of SBP, DBP and total-cholesterol, respectively. In the post-PC period, the percentages were 93.0% for SBP and DBP [p |
Databáze: | OpenAIRE |
Externí odkaz: |